Table 1

Details of inflammatory arthritis subjects in studies 1 and 2

Subject Age Sex ACR criteria RhF Symptoms
duration
(months)
HLA DRβ1 Diagnosis Study
number
263F4N11,2RA1
327F4Y30405,11RA1
457F5Y11,0401RA1
547F4Y100404,0407RA1
751M5Y57,12RA1
1229F4Y22,3RA1
1430F4Y11,0401RA1
1725F4N10404,11RA1
1851F4Y32,11RA1
2175M4N30401RA1
2444F4Y31,0401RA1
2652F4Y42,9RA1
2750F4Y21,0401RA1
2831F4Y120404,6RA1
2955F5Y90401,6RA1
3143M4N61,3RA1
3360M4Y33,0404RA1
3674M4N21,0401RA1
3744F4N42,10RA1
3874M4Y67,0401RA1
142F3Y6NDUndifferentiated1
933F3Y2NDUndifferentiated1
1062M3Y2NDUndifferentiated1
1554F3N61,7Undifferentiated1
1924F3Y37,11Undifferentiated1
2056F3Y41,7Undifferentiated1
2248M3N40401Undifferentiated1
2321M3N211Undifferentiated1
3025F3Y4NDUndifferentiated1
3416F3N63,13Undifferentiated1
657F4N1NDSelf limited1
1335M4N111,13Self limited1
2587F4N22,3Self limited1
3544F3N13,0401Self limited1
868F4N2NDPMR1
1134F4Y2NDSjögrens1
1654F4N1NDEnteropathic1
3257F3N32,0401Psoriatic1
1a26F4Y301,0401RA2
2a79F4Y401,07RA2
3a29F4Y901,02RA2
4a46F4Y301,0401RA2
5a73F4Y303,0401RA2
6a63F4Y302,13RA2
7a88F4N201,03RA2
9a58F4Y903,13RA2
11a72F4Y402,03RA2
12a77M4Y302,03RA2
13a61F4Y302,11RA2
14a72M5Y30401RA2
16a70M4Y40103,07RA2
17a30F4Y202,03RA2
18a72M4N30404,07RA2
21a78M4Y302,0407RA2
  • RhF = rheumatoid factor, ND = not done, PMR = polymyalgia rheumatica.